Pressor response to beta-blocking drugs

M. G. Ziegler; L. C. Woodson

Pressor response to beta-blocking drugs

M. G. Ziegler, L. C. Woodson

Research output: Contribution to journal › Article › peer-review

Abstract

A patient with essential hypertension had a prolonged period of uncontrollable high blood pressure during therapy with the nonspecific beta-blocker nadolol. A subsequent challenge with the beta₁-blocker atenolol caused a pressor response associated with diminished catecholamine release, impaired catecholamine clearance, loss of baroreflex response, and bradycardia. Beta-blocking drugs can lead to hypertension by causing fluid retention, reversal of catecholamine vasodilatation, or a direct pressor effect.

Original language	English (US)
Pages (from-to)	81-88
Number of pages	8
Journal	Clinical Therapeutics
Volume	7
Issue number	1
State	Published - Dec 1 1984

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)

Access to Document

Fingerprint Dive into the research topics of 'Pressor response to beta-blocking drugs'. Together they form a unique fingerprint.

Cite this

@article{8b56a667bf1e4ec39620f4a7340f2d31,

title = "Pressor response to beta-blocking drugs",

abstract = "A patient with essential hypertension had a prolonged period of uncontrollable high blood pressure during therapy with the nonspecific beta-blocker nadolol. A subsequent challenge with the beta1-blocker atenolol caused a pressor response associated with diminished catecholamine release, impaired catecholamine clearance, loss of baroreflex response, and bradycardia. Beta-blocking drugs can lead to hypertension by causing fluid retention, reversal of catecholamine vasodilatation, or a direct pressor effect.",

author = "Ziegler, {M. G.} and Woodson, {L. C.}",

year = "1984",

month = dec,

day = "1",

language = "English (US)",

volume = "7",

pages = "81--88",

journal = "Clinical Therapeutics",

issn = "0149-2918",

publisher = "Excerpta Medica",

number = "1",

}

TY - JOUR

T1 - Pressor response to beta-blocking drugs

AU - Ziegler, M. G.

AU - Woodson, L. C.

PY - 1984/12/1

Y1 - 1984/12/1

N2 - A patient with essential hypertension had a prolonged period of uncontrollable high blood pressure during therapy with the nonspecific beta-blocker nadolol. A subsequent challenge with the beta1-blocker atenolol caused a pressor response associated with diminished catecholamine release, impaired catecholamine clearance, loss of baroreflex response, and bradycardia. Beta-blocking drugs can lead to hypertension by causing fluid retention, reversal of catecholamine vasodilatation, or a direct pressor effect.

AB - A patient with essential hypertension had a prolonged period of uncontrollable high blood pressure during therapy with the nonspecific beta-blocker nadolol. A subsequent challenge with the beta1-blocker atenolol caused a pressor response associated with diminished catecholamine release, impaired catecholamine clearance, loss of baroreflex response, and bradycardia. Beta-blocking drugs can lead to hypertension by causing fluid retention, reversal of catecholamine vasodilatation, or a direct pressor effect.

UR - http://www.scopus.com/inward/record.url?scp=0021710738&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021710738&partnerID=8YFLogxK

M3 - Article

C2 - 6151422

AN - SCOPUS:0021710738

VL - 7

SP - 81

EP - 88

JO - Clinical Therapeutics

JF - Clinical Therapeutics

SN - 0149-2918

IS - 1

ER -